This company listing is no longer active
Lannett Company Dividend
Dividend criteria checks 0/6
Lannett Company does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$24.06 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Lannett announces 1-for-4 reverse stock split
Jan 25Lannett gains on patent deal for biosimilar insulin device
Nov 07Lannett gets FDA approval to manufacture Numbrino® at Seymour plant
Oct 21Lannett Company, Inc. (NYSE:LCI) Analysts Just Slashed This Year's Estimates
Sep 01
Lannett GAAP EPS of -$2.30, revenue of $74.19M
Aug 24Lannett: A Self-Inflicted Crisis
Feb 22Analysts Just Made A Major Revision To Their Lannett Company, Inc. (NYSE:LCI) Revenue Forecasts
Feb 05A Look At The Fair Value Of Lannett Company, Inc. (NYSE:LCI)
Nov 05Is Lannett Company (NYSE:LCI) A Risky Investment?
Jun 20Lannett down 5.5%, SVC gains 5.7% as S&P 500 makes room for Organon
May 27Is Lannett Company (NYSE:LCI) A Risky Investment?
Mar 18Independent Director David Drabik Just Sold A Bunch Of Shares In Lannett Company, Inc. (NYSE:LCI)
Feb 11
Lannett shares slide on 2021 forecast cut, QF2 topline fall
Feb 04What Type Of Returns Would Lannett Company's(NYSE:LCI) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Jan 15Is Lannett Company (NYSE:LCI) Using Too Much Debt?
Dec 11Lannett pays off remaining $42M in outstanding loans
Nov 30Lannett launches authorized generic of Tirosint
Nov 03Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if LCIN.Q's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LCIN.Q's dividend payments have been increasing.
Dividend Yield vs Market
| Lannett Company Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (LCIN.Q) | n/a |
| Market Bottom 25% (US) | 1.6% |
| Market Top 25% (US) | 4.9% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast in 3 Years (LCIN.Q) | n/a |
Notable Dividend: Unable to evaluate LCIN.Q's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LCIN.Q's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as LCIN.Q has not reported any payouts.